🔎 Trials Near Me

Akèy › Skleroz an milti pwogresif kwonik › Illinois › Chicago

Etid klinik pou Skleroz an milti pwogresif kwonik nan Chicago, IL

4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Ap rekriteFaz 3
  • Northwestern Memorial Hospital, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504

Intermittent Hypoxia in Persons With Multiple Sclerosis

Ap rekrite
  • Shirley Ryan AbilityLab, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Mar 20, 2026 · NCT06276634

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Ap rekrite
  • Shirley Ryan AbilityLab, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Feb 23, 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

Ap rekrite
  • University of Illinois at Chicago, Chicago
Laj 40 a 90 · Tout sèks · Mizajou Jan 21, 2026 · NCT07355387

Etid Skleroz an milti pwogresif kwonik nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.